We found that expressions of ED1 and TRAIL were ipsilaterally abundant in the rAAV2/IL12-treated rats (Figure 3B), but less in the PBS-treated rats (Figure 3A); these expressions were most prominent on the last day of Week 3 after tumor implantation. This evidence concerns the gene EDA and neoplasm.